Search

Background: Randomized clinical trials (RCTs) of computer-aided detection (CADe) system-enhanced colonoscopy compared with conventional colonoscopy suggest increased adenoma detection rate (ADR) and decreased adenoma miss rate (AMR), but the effect on detection of advanced colorectal neoplasia (ACN) is unclear., Purpose: To conduct a systematic review to compare performance of CADe-enhanced and conventional colonoscopy., Data Sources: Cochrane Library, Google Scholar, Ovid EMBASE, Ovid MEDLINE, PubMed, Scopus, and Web of Science Core Collection databases were searched through February 2024., Study Selection: Published RCTs comparing CADe-enhanced and conventional colonoscopy., Data Extraction: Average adenoma per colonoscopy (APC) and ACN per colonoscopy were primary outcomes. Adenoma detection rate, AMR, and ACN detection rate (ACN DR) were secondary outcomes. Balancing outcomes included withdrawal time and resection of nonneoplastic polyps (NNPs). Subgroup analyses were done by neural network architecture., Data Synthesis: Forty-four RCTs with 36 201 cases were included. Computer-aided detection-enhanced colonoscopies have higher average APC (12 090 of 12 279 [0.98] vs. 9690 of 12 292 [0.78], incidence rate difference [IRD] = 0.22 [95% CI, 0.16 to 0.28]) and higher ADR (7098 of 16 253 [44.7%] vs. 5825 of 15 855 [36.7%], rate ratio [RR] = 1.21 [CI, 1.15 to 1.28]). Average ACN per colonoscopy was similar (1512 of 9296 [0.16] vs. 1392 of 9121 [0.15], IRD = 0.01 [CI, -0.01 to 0.02]), but ACN DR was higher with CADe system use (1260 of 9899 [12.7%] vs. 1119 of 9746 [11.5%], RR = 1.16 [CI, 1.02 to 1.32]). Using CADe systems resulted in resection of almost 2 extra NNPs per 10 colonoscopies and longer total withdrawal time (0.53 minutes [CI, 0.30 to 0.77])., Limitation: Statistically significant heterogeneity in quality and sample size and inability to blind endoscopists to the intervention in included studies may affect the performance estimates., Conclusion: Computer-aided detection-enhanced colonoscopies have increased APC and detection rate but no difference in ACN per colonoscopy and a small increase in ACN DR. There is minimal increase in procedure time and no difference in performance across neural network architectures., Primary Funding Source: None. (PROSPERO: CRD42023422835)., Competing Interests: Disclosures: Disclosure forms are available with the article online.

Artificial intelligence may improve value in colonoscopy-based colorectal screening and surveillance by improving quality and decreasing unnecessary costs. The quality of screening and surveillance as measured by adenoma detection rates can be improved through real-time computer-assisted detection of polyps. Unnecessary costs can be decreased with optical biopsies to identify low-risk polyps using computer-assisted diagnosis that can undergo the resect-and-discard or diagnose-and-leave strategy. Key challenges include the clinical integration of artificial intelligence-based technology into the endoscopists' workflow, the effect of this technology on endoscopy center efficiency, and the interpretability of the underlying deep learning algorithms. The future for image-based artificial intelligence in gastroenterology will include applications to improve the diagnosis and treatment of cancers throughout the gastrointestinal tract., Competing Interests: Disclosure D.L. Shung: Grant Support through the National Institutes of Health T32 DK007017; M.F. Byrne: CEO and shareholder, Satisfai Health; founder of AI4GI joint venture. Co-development agreement between Olympus America and AI4GI in artificial intelligence and colorectal polyps., (Copyright © 2020 Elsevier Inc. All rights reserved.)